Gemcitabine是一种嘧啶核苷类似物类抗代谢抗肿瘤药物，通过抑制DNA合成与修复，诱导细胞自噬及凋亡；该化合物作为特异性脱氧胞苷类似物，可触发p53依赖性凋亡通路，广泛用于化疗。

-25~-15℃保存，有效期3年

[1] Cai Y, Zhou H, Zhu Y, Sun Q, Ji Y, Xue A, Wang Y, Chen W, Yu X, Wang L, Chen H, Li C, Luo T, Deng H. Elimination of senescent cells by β-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice. Cell Res. 2020 Jul;30(7):574-589. doi: 10.1038/s41422-020-0314-9. Epub 2020 Apr 27. PMID: 32341413; PMCID: PMC7184167.

[2] Yip-Schneider MT, Wu H, Stantz K, Agaram N, Crooks PA, Schmidt CM. Dimethylaminoparthenolide and gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancer. BMC Cancer. 2013 Apr 17;13:194. doi: 10.1186/1471-2407-13-194. PMID: 23590467; PMCID: PMC3672012.